Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5161982 | 0.86 | TRPA1 (0.58) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL13721525 | 0.86 | TRPA1 (0.58) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL29822049 | 0.78 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL353179 | 0.78 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL28573244 | 0.78 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALDH1A1 | |
| SCHEMBL28443386 | 0.78 | ANPEP (0.52) | TRPA1CYP1A2EPHX1TSHRALDH1A1 | |
| SCHEMBL2604925 | 0.78 | TRPA1 (0.55) | TRPA1CYP1A2EPHX1TSHRSLC6A2 | |
| SCHEMBL345523 | 0.78 | TRPA1 (0.55) | TRPA1CYP1A2EPHX1TSHRSLC6A2 | |
| SCHEMBL7906029 | 0.78 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL5689338 | 0.78 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143593-A1 | Process for producing 2-aralkylpropionic acid derivative | KANEKA CORPORATION (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1466895-A1 | PROCESS FOR PRODUCING 2-ARALKYLPROPIONIC ACID DERIVATIVE | KANEKA CORPORATION (JP) | 2004-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143593-A1 | Process for producing 2-aralkylpropionic acid derivative | AASDHPPT, ADSL, HACL2 | TRPA1 828/4885CYP1A2 1178/4885EPHX1 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.